JPS5838300A - 発現因子、それを含有するエシエリヒア属細菌および実質的に純粋なｄｎａセグメント - Google Patents

発現因子、それを含有するエシエリヒア属細菌および実質的に純粋なｄｎａセグメント

Info

Publication number: JPS5838300A
Authority: JP; Japan
Prior art keywords: sequence; expression factor; dna; codon; restriction endonuclease
Prior art date: 1981-08-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP57124278A

Other languages

English (en)

Japanese (ja)

Inventor

ケビン・エム・アルマ−

ジエイムズ・ジエイ・アンダ−ソン

ハ−マン・チユ−

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genex Corp

Original Assignee

Genex Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-08-10

Filing date

1982-07-15

Publication date

1983-03-05

1982-07-15 Application filed by Genex Corp filed Critical Genex Corp

1983-03-05 Publication of JPS5838300A publication Critical patent/JPS5838300A/ja

Status Pending legal-status Critical Current

Links

241000588722 Escherichia Species 0.000 title claims description 5
108090000623 proteins and genes Proteins 0.000 claims description 97
108020004414 DNA Proteins 0.000 claims description 40
108091081024 Start codon Proteins 0.000 claims description 39
108091008146 restriction endonucleases Proteins 0.000 claims description 31
108010042407 Endonucleases Proteins 0.000 claims description 11
102000004533 Endonucleases Human genes 0.000 claims description 11
230000014621 translational initiation Effects 0.000 claims description 11
108020004705 Codon Proteins 0.000 claims description 10
230000000295 complement effect Effects 0.000 claims description 9
150000003839 salts Chemical class 0.000 claims description 8
241000894006 Bacteria Species 0.000 claims description 7
239000012634 fragment Substances 0.000 claims description 6
241000588724 Escherichia coli Species 0.000 claims description 5
230000002068 genetic effect Effects 0.000 claims description 3
239000002773 nucleotide Substances 0.000 claims description 3
125000003729 nucleotide group Chemical group 0.000 claims description 3
244000182625 Dictamnus albus Species 0.000 claims 1
241000210651 Enterobacteria phage 1 Species 0.000 claims 1
229920001184 polypeptide Polymers 0.000 claims 1
108090000765 processed proteins & peptides Proteins 0.000 claims 1
102000004196 processed proteins & peptides Human genes 0.000 claims 1
239000013612 plasmid Substances 0.000 description 58
102000004169 proteins and genes Human genes 0.000 description 29
230000014616 translation Effects 0.000 description 16
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
238000000034 method Methods 0.000 description 14
239000000203 mixture Substances 0.000 description 14
230000015572 biosynthetic process Effects 0.000 description 12
238000003780 insertion Methods 0.000 description 12
230000037431 insertion Effects 0.000 description 12
238000001243 protein synthesis Methods 0.000 description 11
238000003786 synthesis reaction Methods 0.000 description 11
102000004190 Enzymes Human genes 0.000 description 10
108090000790 Enzymes Proteins 0.000 description 10
210000004027 cell Anatomy 0.000 description 9
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
239000000872 buffer Substances 0.000 description 8
108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
238000011534 incubation Methods 0.000 description 7
238000013518 transcription Methods 0.000 description 7
230000035897 transcription Effects 0.000 description 7
101150045500 galK gene Proteins 0.000 description 6
239000011541 reaction mixture Substances 0.000 description 6
102000053602 DNA Human genes 0.000 description 5
108700023157 Galactokinases Proteins 0.000 description 5
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 5
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
230000000977 initiatory effect Effects 0.000 description 5
239000007858 starting material Substances 0.000 description 5
238000013519 translation Methods 0.000 description 5
102000012410 DNA Ligases Human genes 0.000 description 4
108010061982 DNA Ligases Proteins 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
102000048120 Galactokinases Human genes 0.000 description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
238000010586 diagram Methods 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000004048 modification Effects 0.000 description 4
230000001105 regulatory effect Effects 0.000 description 4
238000010367 cloning Methods 0.000 description 3
230000029087 digestion Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000011160 research Methods 0.000 description 3
238000011282 treatment Methods 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
108700039691 Genetic Promoter Regions Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 2
101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
239000006137 Luria-Bertani broth Substances 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
108091000080 Phosphotransferase Proteins 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
TTWYZDPBDWHJOR-IDIVVRGQSA-L adenosine triphosphate disodium Chemical compound [Na+].[Na+].C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O TTWYZDPBDWHJOR-IDIVVRGQSA-L 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000008901 benefit Effects 0.000 description 2
239000000337 buffer salt Substances 0.000 description 2
244000309466 calf Species 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
238000001962 electrophoresis Methods 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
210000002429 large intestine Anatomy 0.000 description 2
229910001629 magnesium chloride Inorganic materials 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
102000020233 phosphotransferase Human genes 0.000 description 2
210000001236 prokaryotic cell Anatomy 0.000 description 2
230000010076 replication Effects 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000004575 stone Substances 0.000 description 2
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
ZMWAXVAETNTVAT-UHFFFAOYSA-N 7-n,8-n,5-triphenylphenazin-5-ium-2,3,7,8-tetramine;chloride Chemical compound [Cl-].C=1C=CC=CC=1NC=1C=C2[N+](C=3C=CC=CC=3)=C3C=C(N)C(N)=CC3=NC2=CC=1NC1=CC=CC=C1 ZMWAXVAETNTVAT-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101100342994 Arabidopsis thaliana IIL1 gene Proteins 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
108091028026 C-DNA Proteins 0.000 description 1
101150061009 C1 gene Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
241000257465 Echinoidea Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
108060002716 Exonuclease Proteins 0.000 description 1
101000609762 Gallus gallus Ovalbumin Proteins 0.000 description 1
101000658566 Haemophilus influenzae Type II restriction enzyme HinfI Proteins 0.000 description 1
102000002265 Human Growth Hormone Human genes 0.000 description 1
108010000521 Human Growth Hormone Proteins 0.000 description 1
239000000854 Human Growth Hormone Substances 0.000 description 1
101150042441 K gene Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
101100293261 Mus musculus Naa15 gene Proteins 0.000 description 1
101100518501 Mus musculus Spp1 gene Proteins 0.000 description 1
101150082943 NAT1 gene Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
230000006819 RNA synthesis Effects 0.000 description 1
108010071390 Serum Albumin Proteins 0.000 description 1
102000007562 Serum Albumin Human genes 0.000 description 1
241000270666 Testudines Species 0.000 description 1
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
230000009471 action Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
150000001413 amino acids Chemical group 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
230000001925 catabolic effect Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
230000010307 cell transformation Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001055 chewing effect Effects 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
230000002860 competitive effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
150000005690 diesters Chemical class 0.000 description 1
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000001545 erythrolytic effect Effects 0.000 description 1
DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
102000013165 exonuclease Human genes 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
238000009472 formulation Methods 0.000 description 1
229930182830 galactose Natural products 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
238000010359 gene isolation Methods 0.000 description 1
239000003292 glue Substances 0.000 description 1
235000013882 gravy Nutrition 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
238000005304 joining Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
210000000265 leukocyte Anatomy 0.000 description 1
239000002502 liposome Substances 0.000 description 1
239000006166 lysate Substances 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000013507 mapping Methods 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
230000035772 mutation Effects 0.000 description 1
MDJFHRLTPRPZLY-UHFFFAOYSA-N nimorazole Chemical compound [O-][N+](=O)C1=CN=CN1CCN1CCOCC1 MDJFHRLTPRPZLY-UHFFFAOYSA-N 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000008188 pellet Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
238000007493 shaping process Methods 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

Genetics & Genomics (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Wood Science & Technology (AREA)
Organic Chemistry (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

JP57124278A 1981-08-10 1982-07-15 発現因子、それを含有するエシエリヒア属細菌および実質的に純粋なｄｎａセグメント Pending JPS5838300A (ja)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US29133481A	1981-08-10	1981-08-10
US291334		1981-08-10

Publications (1)

Publication Number	Publication Date
JPS5838300A true JPS5838300A (ja)	1983-03-05

Family

ID=23119888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP57124278A Pending JPS5838300A (ja)	1981-08-10	1982-07-15	発現因子、それを含有するエシエリヒア属細菌および実質的に純粋なｄｎａセグメント

Country Status (10)

Country	Link
JP (1)	JPS5838300A (fr)
AU (1)	AU8592582A (fr)
BE (1)	BE893837A (fr)
DE (1)	DE3226515A1 (fr)
FR (1)	FR2511033B1 (fr)
GB (1)	GB2104901B (fr)
IE (1)	IE53607B1 (fr)
IL (1)	IL66263A (fr)
IT (1)	IT1156378B (fr)
NL (1)	NL8202851A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1984001583A1 (fr) *	1982-10-08	1984-04-26	Kyowa Hakko Kogyo Kk	Nouveau vecteur
JPS62500212A (ja) *	1984-02-08	1987-01-29	カイロン　コーポレイション	組換操作のための監視及び制御系

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4503142A (en) *	1982-06-25	1985-03-05	Litton Bionetics, Inc.	Open reading frame vectors
EP0121569B1 (fr) *	1982-10-08	1990-08-22	Kyowa Hakko Kogyo Co., Ltd.	Nouveau vecteur
JPS6054685A (ja) *	1983-09-02	1985-03-29	Suntory Ltd	改良発現ベクタ−およびその利用
JPH084507B2 (ja) *	1985-10-03	1996-01-24	武田薬品工業株式会社	新規ｄｎａおよびポリペプチド
FR2598430B1 (fr) *	1986-05-06	1990-02-02	Roussel Uclaf	Nouveaux vecteurs d'expression, leur procede d'obtention et leur application pour exprimer une proteine quelconque dans escherichia coli
JPH04504950A (ja) *	1988-11-23	1992-09-03	ザリージェンツオブザユニバーシティオブカリフォルニア	位置特異的挿入ベクターおよびこれを用いた方法
NL9401678A (nl) *	1994-10-12	1996-05-01	Evert Hovius	Methode van de zichzelf stabiliserende lus (Z.Z.S.L.).

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2450262A1 (fr) *	1979-02-28	1980-09-26	Pasteur Institut	Proteine ayant des proprietes nutritives resultant de l'expression dans une bacterie d'un gene recombinant contenant l'adn correspondant a ladite proteine
SE8101665L (sv) *	1980-03-17	1981-09-18	Harvard College	Polypeptidframstellning
EP0042246B1 (fr) *	1980-06-12	1987-03-18	The Cancer Institute Of Japanese Foundation For Cancer Research	Plasmid

1982
- 1982-07-08 IL IL66263A patent/IL66263A/xx unknown
- 1982-07-12 AU AU85925/82A patent/AU8592582A/en not_active Abandoned
- 1982-07-14 NL NL8202851A patent/NL8202851A/nl not_active Application Discontinuation
- 1982-07-14 IT IT67895/82A patent/IT1156378B/it active
- 1982-07-14 BE BE0/208587A patent/BE893837A/fr not_active IP Right Cessation
- 1982-07-15 GB GB08220597A patent/GB2104901B/en not_active Expired
- 1982-07-15 DE DE19823226515 patent/DE3226515A1/de not_active Withdrawn
- 1982-07-15 FR FR8212368A patent/FR2511033B1/fr not_active Expired
- 1982-07-15 IE IE1707/82A patent/IE53607B1/en unknown
- 1982-07-15 JP JP57124278A patent/JPS5838300A/ja active Pending

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1984001583A1 (fr) *	1982-10-08	1984-04-26	Kyowa Hakko Kogyo Kk	Nouveau vecteur
JPS62500212A (ja) *	1984-02-08	1987-01-29	カイロン　コーポレイション	組換操作のための監視及び制御系

Also Published As

Publication number	Publication date
NL8202851A (nl)	1983-03-01
IT8267895A0 (it)	1982-07-14
FR2511033A1 (fr)	1983-02-11
FR2511033B1 (fr)	1986-08-08
GB2104901A (en)	1983-03-16
GB2104901B (en)	1985-02-06
BE893837A (fr)	1982-11-03
IT1156378B (it)	1987-02-04
IL66263A (en)	1985-12-31
AU8592582A (en)	1983-02-17
IE821707L (en)	1983-02-10
IE53607B1 (en)	1988-12-21
IL66263A0 (en)	1982-11-30
DE3226515A1 (de)	1983-02-17

Publication	Publication Date	Title
US5168062A (en)	1992-12-01	Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4440859A (en)	1984-04-03	Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
EP0035384B1 (fr)	1987-06-10	Segment de désoxyribonucléotides destiné à être rattaché à une séquence codante clonée d'ADN
US4663290A (en)	1987-05-05	Production of reverse transcriptase
US4652525A (en)	1987-03-24	Recombinant bacterial plasmids containing the coding sequences of insulin genes
US5270185A (en)	1993-12-14	High-efficiency cloning of CDNA
JPH0645640B2 (ja)	1994-06-15	雑種ｄｎａおよびそれにより調製される結合性組成物
DD210070A5 (de)	1984-05-30	Verfahren zur herstellung eines polypeptids
Sobel et al.	1978	Construction of a recombinant bacterial plasmid containing a chick pro-alpha2 collagen gene sequence.
JPS6229966A (ja)	1987-02-07	ｐｈｏ　Ａ−変異菌Ｅ・コリ−ＳＢ４４、その製法、これを利用するｐｈｏ　Ａ−遺伝子含有プラスミドの単離法、新規プラスミド及びプラスミドベクタ−、ｐｈｏ　Ａ−遺伝子含有プラスミドの製法、新規菌株の製法及びアルカリホスフアタ−ゼの製法
EP0009930B1 (fr)	1982-07-21	DNA recombinant, méthode pour sa préparation et production de protéines étrangères par des hôtes unicellulaires le contenant
JPH03501925A (ja)	1991-05-09	合成遺伝子
US4322499A (en)	1982-03-30	Adrenocorticotropin-lipotropin precursor gene
JPS62171695A (ja)	1987-07-28	発光蛋白アクアリン遺伝子を用いるアクアリン活性を有する蛋白質の製造法
US4283489A (en)	1981-08-11	Purification of nucleotide sequences suitable for expression in bacteria
US4828988A (en)	1989-05-09	Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine
GB2104901A (en)	1983-03-16	Expression vectors
US4447538A (en)	1984-05-08	Microorganism containing gene for human chorionic somatomammotropin
US4946790A (en)	1990-08-07	Recombinant plasmid for the expression of L-phenylalanine ammonia-lyase and transformed strain carrying same
EP0133321A1 (fr)	1985-02-20	Gène d'ADN, procédé pour sa production et plasmide contenant ce gène
EP0190119A1 (fr)	1986-08-13	Plasmides chimeriques se reproduisant dans des bacteries et dans de la levure; micro-organismes transformes par ceux-ci
US5334531A (en)	1994-08-02	Plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone
EP0469523A2 (fr)	1992-02-05	Clonage et surexpression de l'hydrogenase de glucose-6 phosphate de Leuconostoc dextranicus
IE57985B1 (en)	1993-06-02	Improved plasmid vector and use thereof
EP0622460A2 (fr)	1994-11-02	Plasmid et E. coli transformé par ledit plasmid

JPS5838300A - 発現因子、それを含有するエシエリヒア属細菌および実質的に純粋なｄｎａセグメント - Google Patents

Info

Links

Classifications

Landscapes

Applications Claiming Priority (2)

Publications (1)

Family

ID=23119888

Family Applications (1)

Country Status (10)

Cited By (2)

Families Citing this family (7)

Family Cites Families (3)

Cited By (2)

Also Published As

Similar Documents